10 20 30 40 50 60 70 80 1ERG - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER COMPLEMENT FACTOR 13-DEC-93 1ERG
TITLE THREE-DIMENSIONAL SOLUTION STRUCTURE OF THE EXTRACELLULAR TITLE 2 REGION OF THE COMPLEMENT REGULATORY PROTEIN, CD59, A NEW TITLE 3 CELL SURFACE PROTEIN DOMAIN RELATED TO NEUROTOXINS
COMPND MOL_ID: 1; COMPND 2 MOLECULE: CD59; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606
KEYWDS COMPLEMENT FACTOR
EXPDTA SOLUTION NMR
AUTHOR B.KIEFFER,P.C.DRISCOLL,I.D.CAMPBELL,A.C.WILLIS,P.A.VAN DER AUTHOR 2 MERWE,S.J.DAVIS
REVDAT 2 24-FEB-09 1ERG 1 VERSN REVDAT 1 30-APR-94 1ERG 0
JRNL AUTH B.KIEFFER,P.C.DRISCOLL,I.D.CAMPBELL,A.C.WILLIS, JRNL AUTH 2 P.A.VAN DER MERWE,S.J.DAVIS JRNL TITL THREE-DIMENSIONAL SOLUTION STRUCTURE OF THE JRNL TITL 2 EXTRACELLULAR REGION OF THE COMPLEMENT REGULATORY JRNL TITL 3 PROTEIN CD59, A NEW CELL-SURFACE PROTEIN DOMAIN JRNL TITL 4 RELATED TO SNAKE VENOM NEUROTOXINS. JRNL REF BIOCHEMISTRY V. 33 4471 1994 JRNL REFN ISSN 0006-2960 JRNL PMID 7512825 JRNL DOI 10.1021/BI00181A006
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1ERG COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.
REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : NULL REMARK 210 PH : NULL REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NULL REMARK 210 SPECTROMETER FIELD STRENGTH : NULL REMARK 210 SPECTROMETER MODEL : NULL REMARK 210 SPECTROMETER MANUFACTURER : NULL REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : NULL REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : NULL REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL
REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS.
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 9 86.80 -56.88 REMARK 500 LYS A 14 32.02 -152.86 REMARK 500 THR A 15 149.04 -32.58 REMARK 500 SER A 20 -99.38 -118.28 REMARK 500 SER A 21 -75.60 73.61 REMARK 500 PHE A 42 -52.18 -17.63 REMARK 500 GLU A 43 39.44 -78.66 REMARK 500 CYS A 45 53.27 -90.77 REMARK 500 ASN A 46 -84.97 -77.34 REMARK 500 PHE A 47 -94.44 -122.59 REMARK 500 ARG A 55 108.39 77.79 REMARK 500 ASN A 57 -96.81 160.25 REMARK 500 LEU A 59 -152.57 -73.76 REMARK 500 THR A 60 72.03 -161.22 REMARK 500 LYS A 65 58.00 -150.84 REMARK 500 LYS A 66 -44.04 -143.95 REMARK 500 ASP A 67 -163.49 -174.65 REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: PYB REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: NULL
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ERH RELATED DB: PDB
DBREF 1ERG A 1 70 UNP P13987 CD59_HUMAN 26 95
SEQRES 1 A 70 LEU GLN CYS TYR ASN CYS PRO ASN PRO THR ALA ASP CYS SEQRES 2 A 70 LYS THR ALA VAL ASN CYS SER SER ASP PHE ASP ALA CYS SEQRES 3 A 70 LEU ILE THR LYS ALA GLY LEU GLN VAL TYR ASN LYS CYS SEQRES 4 A 70 TRP LYS PHE GLU HIS CYS ASN PHE ASN ASP VAL THR THR SEQRES 5 A 70 ARG LEU ARG GLU ASN GLU LEU THR TYR TYR CYS CYS LYS SEQRES 6 A 70 LYS ASP LEU CYS ASN
HELIX 1 H1 PHE A 47 LEU A 54 11/5 NOT WELL-DEFINED BY NMR 8
SHEET 1 B1 2 CYS A 3 ASN A 5 0 SHEET 2 B1 2 THR A 15 VAL A 17 -1 O VAL A 17 N CYS A 3 SHEET 1 B2 3 TYR A 36 TRP A 40 0 SHEET 2 B2 3 ALA A 25 LYS A 30 -1 N ALA A 25 O TRP A 40 SHEET 3 B2 3 TYR A 62 CYS A 64 -1 O CYS A 64 N CYS A 26
SSBOND 1 CYS A 3 CYS A 26 1555 1555 2.02 SSBOND 2 CYS A 6 CYS A 13 1555 1555 2.03 SSBOND 3 CYS A 19 CYS A 39 1555 1555 2.02 SSBOND 4 CYS A 45 CYS A 63 1555 1555 2.02 SSBOND 5 CYS A 64 CYS A 69 1555 1555 2.02
SITE 1 PYB 3 THR A 29 PHE A 47 CYS A 69
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000